Ulrike Gern

1.1k total citations
15 papers, 817 citations indexed

About

Ulrike Gern is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ulrike Gern has authored 15 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Ulrike Gern's work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Ulrike Gern is often cited by papers focused on CAR-T cell therapy research (10 papers), Virus-based gene therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Ulrike Gern collaborates with scholars based in Germany, Belgium and United States. Ulrike Gern's co-authors include Thomas Seufferlein, Guido Adler, Michael Schmitt, Anita Schmitt, Maria‐Luisa Schubert, Carsten Müller‐Tidow, Leopold Sellner, Peter Dreger, Lei Wang and Brigitte Neuber and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Cell Biology.

In The Last Decade

Ulrike Gern

15 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrike Gern Germany	14	360	330	184	154	135	15	817
Ana Kostić United States	15	484 1.3×	283 0.9×	342 1.9×	184 1.2×	109 0.8×	39	990
Jenny J. Hong United States	12	800 2.2×	614 1.9×	202 1.1×	108 0.7×	448 3.3×	23	1.4k
John T. Kemshead United Kingdom	18	437 1.2×	464 1.4×	77 0.4×	130 0.8×	225 1.7×	35	1.2k
Kyle Dyson United States	11	425 1.2×	227 0.7×	40 0.2×	220 1.4×	296 2.2×	19	796
Shahar Frenkel Israel	22	399 1.1×	556 1.7×	96 0.5×	89 0.6×	183 1.4×	78	1.6k
Douglas Houghton Campbell Australia	18	273 0.8×	503 1.5×	245 1.3×	173 1.1×	94 0.7×	48	1.0k
Megan M. Davis United States	12	804 2.2×	493 1.5×	58 0.3×	230 1.5×	288 2.1×	28	1.1k
Alex Lee United States	13	218 0.6×	687 2.1×	81 0.4×	98 0.6×	143 1.1×	25	1.0k
Paul R. Jamieson Australia	10	414 1.1×	477 1.4×	84 0.5×	215 1.4×	61 0.5×	11	900
Mihaela Lorger United Kingdom	17	523 1.5×	492 1.5×	80 0.4×	149 1.0×	207 1.5×	29	1.2k

Countries citing papers authored by Ulrike Gern

Since Specialization

Citations

This map shows the geographic impact of Ulrike Gern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Gern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Gern more than expected).

Fields of papers citing papers by Ulrike Gern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Gern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Gern. The network helps show where Ulrike Gern may publish in the future.

Co-authorship network of co-authors of Ulrike Gern

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Gern. A scholar is included among the top collaborators of Ulrike Gern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Gern. Ulrike Gern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Yoo, Keun-Young, Sophia Stock, Lei Wang, et al.. (2020). Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. International Journal of Cancer. 148(2). 419–428. 52 indexed citations

Kunz, Alexander, Ulrike Gern, Anita Schmitt, et al.. (2020). Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients. Molecular Therapy — Methods & Clinical Development. 17. 448–454. 28 indexed citations

Yoo, Keun-Young, Yibin Liu, Lei Wang, et al.. (2019). Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. International Journal of Molecular Sciences. 20(10). 2469–2469. 15 indexed citations

Wang, Lei, Wenjie Gong, Sanmei Wang, et al.. (2019). Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells. Cytotherapy. 21(5). 566–578. 17 indexed citations

Schubert, Maria‐Luisa, Anita Schmitt, Leopold Sellner, et al.. (2019). Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol. BMJ Open. 9(5). e026644–e026644. 33 indexed citations

Gong, Wenjie, Jean‐Marc Hoffmann, Sophia Stock, et al.. (2019). Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells. Cancer Immunology Immunotherapy. 68(7). 1195–1209. 41 indexed citations

Schubert, Maria‐Luisa, Anita Schmitt, Brigitte Neuber, et al.. (2019). Third-Generation CAR T Cells Targeting CD19 Are Associated with an Excellent Safety Profile and Might Improve Persistence of CAR T Cells in Treated Patients. Blood. 134(Supplement_1). 51–51. 42 indexed citations

Stock, Sophia, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.. (2018). Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Human Gene Therapy. 29(10). 1167–1182. 21 indexed citations

Hoffmann, Jean‐Marc, Maria‐Luisa Schubert, Lei Wang, et al.. (2018). Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients. Frontiers in Immunology. 8. 1956–1956. 83 indexed citations

10.

Malcherek, Georg, Nan Jin, Angela Hückelhoven, et al.. (2014). Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells. Leukemia. 28(12). 2388–2394. 23 indexed citations

11.

Beil, Michael, Alexandre Micoulet, Götz von Wichert, et al.. (2003). Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nature Cell Biology. 5(9). 803–811. 218 indexed citations

12.

Baust, Heinrich, Ulrike Gern, Marek Łoś, et al.. (2003). Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-κB independent mechanisms. Oncogene. 22(54). 8786–8796. 10 indexed citations

13.

Lint, Johan Van, Monika Wilda, H. Hameister, et al.. (2001). Molecular Cloning and Characterization of the Human Protein Kinase D2. Journal of Biological Chemistry. 276(5). 3310–3318. 159 indexed citations

14.

Melms, Arthur, Georg Malcherek, Ulrike Gern, et al.. (1993). Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.. Journal of Neurology Neurosurgery & Psychiatry. 56(1). 46–51. 16 indexed citations

15.

Melms, Arthur, Georg Malcherek, Ulrike Gern, et al.. (1992). T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Heterogeneity of antigenic sites on the α‐subunit. Annals of Neurology. 31(3). 311–318. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact